Big Data per sviluppo nuovi vaccini

Innovery e CNR insieme per lo sviluppo di una piattaforma tecnologica in grado di analizzare milioni di dati per scoprire piccole molecole di origine marina. Molecole da utilizzare poi come chemioterapici immunogenici, agenti chemio preventivi e vaccini terapeutici antitumorali. Nasce la piattaforma, denominata ADViSE (Antitumor Drugs and Vaccines from the Sea) Leggi l’articolo: Big Data…

Big Data e Intelligenza Artificiale per lo studio di nuovi immunoterapici e vaccini da molecole marine

Il progresso scientifico, negli ultimi decenni, ha apportato importanti e significative conoscenze sulla struttura e funzione delle molecole biologiche e sulla loro alterazione quale causa di molte malattie, come ad esempio tumori, patologie legate a disordini o disfunzioni del sistema immunitario e malattie degenerative. Da queste scoperte la ricerca scientifica sta esplorando l’utilizzo sempre maggiore…

Security Assessment

Security Assessment A Security Assessment is the measurement of a company’s security posture and aims to reveal any possible flaws in the systems, in order to define the correct countermeasures. Security Assessments rely on: • Vulnerability Assessment, which is mainly conducted automatically with the objective to find out all the vulnerabilities in the systems •…

OFFENSIVE SECURITY

SECURITY ASSESSMENTClick to view detailADVANCED SECURITY SERVICESClick to view detailCERTIFICATIONSClick to view detailINNOVERY: EXPERTISE AND EXPERIENCESince 2019 following Wise investments, Innovery aims at further accelerating its expansion by fostering the organic growth, leveraging existing and building new relationships, and by implementing a M&A strategy to develop products, services and markets internationally.

PARTNERS | IBM

Our history with IBM Sterling +16 years of experience not in the Sterling portfolio 2011 IBM Sterling Premium Channel Business Partner 2016 IBM Sterling Gold Accreditation 2020-2021 IBM Sterling Gold Business Partner +16 years as a service provider / service provider on the Sterling platform +30 of the world’s leading financial institutions are our clients…

ADViSE – Antitumor Drugs And Vaccines From The SEa

Project co-financed by the European Union, the Italian State and Regione Campania, as part of the POR Campania ERDF 2014-2020 with a subsidy in the form of a grant.   The Antitumor Drugs and Vaccines from the SEa (ADViSE) Project, with the code 1706BP000000011, aims to provide a new perspective of innovation in drug discovery processes for the fight against oncological pathologies (LC, Mel, MMi) *, by activating a new modality of collaboration between the world of research and innovation, through: 1. The development of antitumoral vaccine models; 2. the identification of new chemotherapy molecules also provided with immunomodulating activity of natural origin.  To achieve this goal, the aim is to create a regional experimentation hub for the early identification of tumors, the characterization of the resistance profile and the creation of alternative therapies for patients who do not respond to conventional therapies. With these premises, the purposes of the ADViSE Platform are:  Preclinical development of new chemotherapeutical agents with immunomodulating action, based on the principle of combining the two actions, using a platform for the selection and validation of oncological drug discovery, which already in the past, in…